Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
H.I.G. Capital has agreed to acquire Navitas Life Sciences
BioAgilytix has agreed to acquire 360biolabs for approximately $290mm
Reify Health has raised $220mm in a round of funding led by Coatue